vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $47.3M, roughly 1.0× Mama's Creations, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -4.8%, a 5.9% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $3.7M). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
IRWD vs MAMA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | ||
|---|---|---|
| Revenue | $47.7M | $47.3M |
| Net Profit | $-2.3M | $540.0K |
| Gross Margin | — | 23.6% |
| Operating Margin | 14.3% | 1.7% |
| Net Margin | -4.8% | 1.1% |
| Revenue YoY | -47.3% | 50.0% |
| Net Profit YoY | -200.9% | 31.7% |
| EPS (diluted) | $0.01 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $47.3M | ||
| Q3 25 | $122.1M | $35.2M | ||
| Q2 25 | $85.2M | $35.3M | ||
| Q1 25 | $41.1M | $33.6M | ||
| Q4 24 | $90.5M | $31.5M | ||
| Q3 24 | $91.6M | $28.4M | ||
| Q2 24 | $94.4M | $29.8M | ||
| Q1 24 | $74.9M | $26.7M |
| Q4 25 | $-2.3M | $540.0K | ||
| Q3 25 | $40.1M | $1.3M | ||
| Q2 25 | $23.6M | $1.2M | ||
| Q1 25 | $-37.4M | $1.6M | ||
| Q4 24 | $2.3M | $410.0K | ||
| Q3 24 | $3.6M | $1.1M | ||
| Q2 24 | $-860.0K | $553.0K | ||
| Q1 24 | $-4.2M | $1.4M |
| Q4 25 | — | 23.6% | ||
| Q3 25 | — | 24.9% | ||
| Q2 25 | — | 26.1% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 24.2% | ||
| Q2 24 | — | 25.0% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | 14.3% | 1.7% | ||
| Q3 25 | 61.8% | 4.8% | ||
| Q2 25 | 53.2% | 4.5% | ||
| Q1 25 | -70.7% | 5.7% | ||
| Q4 24 | 34.8% | 1.8% | ||
| Q3 24 | 28.0% | 5.7% | ||
| Q2 24 | 26.5% | 2.6% | ||
| Q1 24 | 14.7% | 7.4% |
| Q4 25 | -4.8% | 1.1% | ||
| Q3 25 | 32.8% | 3.6% | ||
| Q2 25 | 27.7% | 3.5% | ||
| Q1 25 | -90.9% | 4.8% | ||
| Q4 24 | 2.5% | 1.3% | ||
| Q3 24 | 4.0% | 4.0% | ||
| Q2 24 | -0.9% | 1.9% | ||
| Q1 24 | -5.6% | 5.3% |
| Q4 25 | $0.01 | $0.01 | ||
| Q3 25 | $0.23 | $0.03 | ||
| Q2 25 | $0.14 | $0.03 | ||
| Q1 25 | $-0.23 | $0.04 | ||
| Q4 24 | $0.03 | $0.01 | ||
| Q3 24 | $0.02 | $0.03 | ||
| Q2 24 | $-0.01 | $0.01 | ||
| Q1 24 | $-0.03 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $18.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $49.6M |
| Total Assets | $396.9M | $84.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $18.1M | ||
| Q3 25 | $140.4M | $9.4M | ||
| Q2 25 | $92.9M | $12.0M | ||
| Q1 25 | $108.5M | $7.2M | ||
| Q4 24 | $88.6M | $9.3M | ||
| Q3 24 | $88.2M | $7.4M | ||
| Q2 24 | $105.5M | $13.0M | ||
| Q1 24 | $121.5M | $11.0M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $49.6M | ||
| Q3 25 | $-264.2M | $29.6M | ||
| Q2 25 | $-308.2M | $26.4M | ||
| Q1 25 | $-334.1M | $24.9M | ||
| Q4 24 | $-301.3M | $23.0M | ||
| Q3 24 | $-311.3M | $22.3M | ||
| Q2 24 | $-321.7M | $20.3M | ||
| Q1 24 | $-330.5M | $19.6M |
| Q4 25 | $396.9M | $84.0M | ||
| Q3 25 | $396.1M | $51.2M | ||
| Q2 25 | $342.9M | $52.7M | ||
| Q1 25 | $327.2M | $47.1M | ||
| Q4 24 | $350.9M | $47.9M | ||
| Q3 24 | $389.5M | $43.0M | ||
| Q2 24 | $395.6M | $47.2M | ||
| Q1 24 | $438.8M | $45.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $3.9M |
| Free Cash FlowOCF − Capex | $74.6M | $3.7M |
| FCF MarginFCF / Revenue | 156.3% | 7.8% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 7.16× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $6.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $3.9M | ||
| Q3 25 | $47.6M | $-1.7M | ||
| Q2 25 | $-15.1M | $6.0M | ||
| Q1 25 | $20.0M | $-857.0K | ||
| Q4 24 | $15.2M | $4.8M | ||
| Q3 24 | $9.9M | $-2.4M | ||
| Q2 24 | $33.5M | $3.6M | ||
| Q1 24 | $45.0M | $6.7M |
| Q4 25 | $74.6M | $3.7M | ||
| Q3 25 | $47.6M | $-2.2M | ||
| Q2 25 | $-15.1M | $5.5M | ||
| Q1 25 | $19.9M | $-930.0K | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $9.9M | $-4.0M | ||
| Q2 24 | $33.4M | $2.5M | ||
| Q1 24 | $44.9M | $6.6M |
| Q4 25 | 156.3% | 7.8% | ||
| Q3 25 | 39.0% | -6.2% | ||
| Q2 25 | -17.7% | 15.5% | ||
| Q1 25 | 48.4% | -2.8% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 10.8% | -14.1% | ||
| Q2 24 | 35.4% | 8.4% | ||
| Q1 24 | 60.0% | 24.8% |
| Q4 25 | 0.0% | 0.4% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 7.2% | ||
| Q3 24 | 0.0% | 5.6% | ||
| Q2 24 | 0.1% | 3.8% | ||
| Q1 24 | 0.1% | 0.4% |
| Q4 25 | — | 7.16× | ||
| Q3 25 | 1.19× | -1.31× | ||
| Q2 25 | -0.64× | 4.85× | ||
| Q1 25 | — | -0.54× | ||
| Q4 24 | 6.74× | 11.71× | ||
| Q3 24 | 2.71× | -2.10× | ||
| Q2 24 | — | 6.58× | ||
| Q1 24 | — | 4.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.